Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

Published:2018-11-06 Issue:2 Volume:18 Page:437-447
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Papadaki Maria A.,Stoupis Giannis,Theodoropoulos Panayiotis A.,Mavroudis Dimitris,Georgoulias Vassilis,Agelaki Sofia

Funder

Maria-Michail Manassaki Foundation, Heraklion, Greece

Anticancer Research Support Association (ARSA), Heraklion, Greece

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer;Cancers;2024-08-23

2. Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression;International Journal of Molecular Sciences;2024-08-17

3. IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial–mesenchymal transition;Cell Communication and Signaling;2024-08-08

4. Phenotypic Plasticity and Cancer: A System Biology Perspective;Journal of Clinical Medicine;2024-07-23

5. Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2024-06-27